Literature DB >> 16906756

Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.

Alexandra S Zlatarova1, Marieta Rouseva, Lubka T Roumenina, Mihaela Gadjeva, Martin Kolev, Ivan Dobrev, Neli Olova, Rohit Ghai, Jens Chr Jensenius, Kenneth B M Reid, Uday Kishore, Mihaela S Kojouharova.   

Abstract

C1q is the first subcomponent of the classical complement pathway that binds antigen-bound IgG or IgM and initiates complement activation via association of serine proteases C1r and C1s. The globular domain of C1q (gC1q), which is the ligand-recognition domain, is a heterotrimeric structure composed of the C-terminal regions of A (ghA), B (ghB), and C (ghC) chains. The expression and functional characterization of ghA, ghB, and ghC modules have revealed that each chain has some structural and functional autonomy. Although a number of studies have tried to identify IgG-binding sites on the gC1q domain, no such attempt has been made to localize IgM-binding site. On the basis of the information available via the gC1q crystal structure, molecular modeling, mutational studies, and bioinformatics, we have generated a series of substitution mutants of ghA, ghB, and ghC and examined their interactions with IgM. The comparative analysis of IgM- and IgG-binding abilities of the mutants suggests that the IgG- and IgM-binding sites within the gC1q domain are different but may overlap. Whereas Arg(B108), Arg (B109), and Tyr(B175) mainly constitute the IgM-binding site, the residues Arg(B114), Arg(B129), Arg(B163), and His(B117) that have been shown to be central to IgG binding are not important for the C1q-IgM interaction. Given the location of Arg(B108), Arg (B109), and Tyr(B175) in the gC1q crystal structure, it is likely that C1q interacts with IgM via the top of the gC1q domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906756     DOI: 10.1021/bi060539v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Making autoantibodies safe.

Authors:  Christopher N Scanlan; Dennis R Burton; Raymond A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-14       Impact factor: 11.205

2.  Neutrophil-mediated lung permeability and host defense proteins.

Authors:  Stephen P Kantrow; Zhiwei Shen; Tonya Jagneaux; Ping Zhang; Steve Nelson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-31       Impact factor: 5.464

3.  The human IgM pentamer is a mushroom-shaped molecule with a flexural bias.

Authors:  Daniel M Czajkowsky; Zhifeng Shao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

Review 4.  C1q: A fresh look upon an old molecule.

Authors:  Nicole M Thielens; Francesco Tedesco; Suzanne S Bohlson; Christine Gaboriaud; Andrea J Tenner
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

5.  Kingella kingae Surface Polysaccharides Promote Resistance to Human Serum and Virulence in a Juvenile Rat Model.

Authors:  Vanessa L Muñoz; Eric A Porsch; Joseph W St Geme
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

Review 6.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

7.  In silico and in vitro studies on the protein-protein interactions between Brugia malayi immunomodulatory protein calreticulin and human C1q.

Authors:  Sunita Yadav; Smita Gupta; Chandrabose Selvaraj; Pawan Kumar Doharey; Anita Verma; Sanjeev Kumar Singh; Jitendra Kumar Saxena
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 8.  Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.

Authors:  Katherine E Lintner; Yee Ling Wu; Yan Yang; Charles H Spencer; Georges Hauptmann; Lee A Hebert; John P Atkinson; C Yung Yu
Journal:  Front Immunol       Date:  2016-02-15       Impact factor: 7.561

Review 9.  Keeping It All Going-Complement Meets Metabolism.

Authors:  Martin Kolev; Claudia Kemper
Journal:  Front Immunol       Date:  2017-01-18       Impact factor: 7.561

10.  Is the A-Chain the Engine That Drives the Diversity of C1q Functions? Revisiting Its Unique Structure.

Authors:  Berhane Ghebrehiwet; Evelyn Kandov; Uday Kishore; Ellinor I B Peerschke
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.